In adults with non-alcoholic fatty liver disease, serum Tβ4 was lower than in healthy controls.
In plain wordsIn adults with fatty liver disease, the body's own thymosin beta‑4 level in blood was lower than in healthy people.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- DecreaseSerum Tβ4 level in NAFLD versus healthy controls
- Study
n = 206
- Comparator
- Healthy controls
- Outcome group
- Liver fat and liver function · Liver
Measurements
- Serum Tβ4
- 3.2 mg/l
- NAFLD patients
- Serum Tβ4
- 5.53 mg/l
- healthy controls
Source sentences
serum Tβ4 content was 3.20 ± 0.98 mg/l in NAFLD patients (n = 76) and 5.53 ± 1.24 mg/l in healthy controls (n = 130); the difference between the two groups was statistically significant (p = 0.000).
2 context sentences(design, population, supporting numbers)
a total of 76 NAFLD patients and 130 healthy controls were included in the study.
Serum levels of Tβ4, IL-6 and adiponectin were determined by ELISA.
This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.